Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,260,649
+$412,159 QoQ
Shares Held
39,948
+4.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#233
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Trust Co holds $201,801,045 across 13 Drug Manufacturers - General names. NVS ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
198,148 | $49,861,961 | |
| 2 | JNJ |
Johnson & Johnson
|
191,349 | $48,596,904 | |
| 3 | LLY |
ELI LILLY & Co
|
29,355 | $35,209,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
204,960 | $26,337,359 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
86,362 | $10,910,974 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
134,450 | $7,747,007 | |
| 7 | AMGN |
Amgen Inc
|
20,391 | $7,383,988 | |
| 8 | NVS |
Novartis AG
This page
|
39,948 | $6,260,649 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,260,649 | 39,948 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,848,490 | 38,288 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,560,708 | 40,333 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,134,985 | 40,042 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,706,682 | 38,895 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,108,817 | 36,857 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $3,466,473 | 35,623 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,027,424 | 35,015 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,787,313 | 35,575 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,288,916 | 34,001 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,475,184 | 34,418 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,541,568 | 34,769 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $3,523,877 | 34,921 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,290,012 | 35,761 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,124,214 | 34,438 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,835,248 | 37,301 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,080,610 | 36,444 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $3,211,649 | 36,600 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,223,531 | 36,853 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,121,787 | 38,173 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $3,467,484 | 38,004 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $3,219,603 | 37,665 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,471,150 | 36,759 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $3,469,528 | 39,898 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,339,618 | 38,237 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $2,846,832 | 34,528 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||